Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cognetivity Neurosciences Ltd C.CGN

Alternate Symbol(s):  CGNSF

Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia.


Stock Price Chart (CSE:CGN)

Fundamentals Snapshot (CSE:CGN)

Opinion & Analysis (CSE:CGN)

No current opinion is available.

Bullboard Posts (CSE:CGN)

RE:Are we halted?

Nope, that was weird!
jolew32 - 4 days ago

Are we halted?

Offer is showing $1.50
jolew32 - 4 days ago

RE:Cognetivity Sees Pilot Program Transition Into Commercial Ag

Just holding, waiting for them to continue Advancement. Adoption takes time but someone has been accumulating the stock..
tinkvid - 4 days ago

Cognetivity Sees Pilot Program Transition Into Commercial Ag

A successful pilot program has lead to a commercial arrangement for Cognetivity Neurosciences. The firm this morning revealed that its...
AwareInvestor - June 15, 2022

Cognetivity To Deploy Cognitive Assessment Tool Across Large

Cognetivity Neurosciences continued to take the Middle East by storm this morning. The firm has continued its pattern of signing with...
AwareInvestor - June 2, 2022

Dementia figures

Globally, dementia costs US$ 1.3 trillion and is projected to increase to US$ 1.7 trillion by 2030, or US$ 2.8 trillion if corrected for...
drd8 - May 31, 2022